A Phase 2 depression study for adults in Austin (TARIAN-1)
A Phase 2 study testing an experimental once-daily medication for depression in adults, compared with an inactive pill.
What to expect
~8 in-person clinic visits over 4 months
Mood and wellbeing questionnaires
Cognitive assessments and blood draws
Physical exam and ECG
Once-daily oral capsule taken at home
A Day 3 phone check-in
You may be a fit if
Age 18–75
Recurrent MDD with prior episodes
Current episode lasting 6+ weeks
Able to attend visits in Austin
Willing to discontinue current antidepressants if needed
More about this study
Read the full details, including what taking part involves and answers to common questions, on the study's information page.
Registry details
This study is registered as NCT07300969: see every site, the full eligibility criteria and the official record.
A few quick questions. No obligation, and your answers stay private.